The Largest and Longest-Running Event Devoted to Designing Reliable Assays and Safer Molecules, and Setting Industry-Leading Strategies to Ensure the Safety of Follow-On Biologics

Now in its 13th year, "Immunogenicity for Biotherapeutics" is the one event that helps you target the most valid and efficient methods in order to yield consistent and reliable results.